Pfizer files new patent suits against Ranbaxy

03/26/2008 | Bloomberg

Pfizer has sued Ranbaxy Laboratories Ltd. in federal court in Delaware to block Ranbaxy's generic versions of Lipitor and Caduet until patents tied to the cholesterol drugs lapse in 2016. Ranbaxy, already barred from marketing copies of the medicines until 2010, declined to comment on the case.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care